KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oaktree Specialty Lending (OCSL) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Oaktree Specialty Lending (OCSL) over the last 13 years, with Q4 2025 value amounting to $80.8 million.

  • Oaktree Specialty Lending's Cash & Equivalents fell 2842.9% to $80.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $80.8 million, marking a year-over-year decrease of 2842.9%. This contributed to the annual value of $79.6 million for FY2025, which is 2448.8% up from last year.
  • According to the latest figures from Q4 2025, Oaktree Specialty Lending's Cash & Equivalents is $80.8 million, which was down 2842.9% from $79.6 million recorded in Q3 2025.
  • Oaktree Specialty Lending's 5-year Cash & Equivalents high stood at $20.2 billion for Q4 2021, and its period low was $17.4 million during Q4 2022.
  • For the 5-year period, Oaktree Specialty Lending's Cash & Equivalents averaged around $4.0 billion, with its median value being $97.1 million (2024).
  • In the last 5 years, Oaktree Specialty Lending's Cash & Equivalents tumbled by 9991.39% in 2022 and then surged by 54646.76% in 2023.
  • Oaktree Specialty Lending's Cash & Equivalents (Quarter) stood at $20.2 billion in 2021, then plummeted by 99.91% to $17.4 million in 2022, then surged by 546.47% to $112.4 million in 2023, then rose by 0.48% to $112.9 million in 2024, then dropped by 28.43% to $80.8 million in 2025.
  • Its Cash & Equivalents stands at $80.8 million for Q4 2025, versus $79.6 million for Q3 2025 and $79.8 million for Q2 2025.